The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1979, 122: 2424-2429.
Copyright © 1979 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ochs, U. H.
Right arrow Articles by Scott, C. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ochs, U. H.
Right arrow Articles by Scott, C. R.

Purine Nucleoside Phosphorylase Deficiency: A Molecular Model for Selective Loss of T Cell Function1

Ute H. Ochs, Shi-Han Chen, Hans D. Ochs2, William R. A. Osborne and C. Ronald Scott

From the Department of Pediatrics, University of Washington, School of Medicine, Seattle, Washington 98195

Abstract

Absence of purine nucleoside phosphorylase (NP) is associated with severe T cell immune deficiency and normal B cell function. Patients with this enzyme defect accumulate inosine, guanosine, and their respective deoxycompounds, all of which are substrates for NP. We have evaluated the effect of these four NP substrates on PHA-stimulated lymphocytes and lymphoblastoid cell lines with B and T cell characteristics. Inosine and deoxyinosine had little inhibitory effect on human lymphocytes, whereas guanosine and deoxyguanosine inhibited DNA and protein synthesis in both PHA-stimulated human lymphocytes and hyman lymphoblastoid cells. In all experiments, deoxyguanosine was more toxic than guanosine.

Human lymphoblastoid cells with T cell characteristics (T-LCL) were found to be particularly sensitive to the presence of deoxyguanosine. At low µM concentrations 3H-thymidine and 3H-leucine incorporation into the T-LCL was markedly decreased. At a concentration of 10 µM, no cell growth occurred and 50% of the cells were killed. Partial reversal of the toxic effect of deoxyguanosine on the T-LCL could be achieved with simultaneous addition of deoxycytidine. Human lymphoblastoid cells with B cell characteristics (B-LCL) were not inhibited at these low deoxyguanosine levels but cell growth and incorporation of 3H-thymidine and 3H-leucine were moderately decreased at higher deoxyguanosine concentrations. In a B-LCL established from a patient with NP deficiency, neither DNA nor protein synthesis was inhibited by guanosine or deoxyguanosine at concentrations that affected other B cell lines.

The extreme sensitivity of the T lymphoblasts and relative resistance of B lymphoblasts to the toxicity of deoxyguanosine or one of its metabolic products may explain the selective loss of T cell function in patients with NP deficiency.

Footnotes

1 This work was supported in part by Public Health Service Grants GM 01218 and AI 12617, and the National Foundation.

2 Dr. H. D. Ochs is an investigator of the Howard Hughes Medical Institute.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1979 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1979 by The American Association of Immunologists, Inc. All rights reserved.